TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd.
This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.
Brief Summary
Quantum BioPharma Ltd. is pleased to announce the appointment of Zappy as CEO of its licensee, Unbuzzd Wellness. This strategic leadership change aims to drive forward the development of an innovative alcohol metabolism accelerant, clinically validated for enhancing health outcomes.
Key highlights from the announcement include:
- Appointment of Zappy as CEO to lead Unbuzzd Wellness.
- Focus on clinically validated alcohol metabolism enhancement.
- Positioning Unbuzzd Wellness as a leader in wellness innovations.
- Broader health implications for alcohol consumption.
- Future collaboration opportunities with health experts.
Why it matters: This strategic move may revolutionize wellness solutions related to alcohol metabolism, potentially impacting consumer health trends and investor interest.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.